http://purl.org/np/RAwtpEE2QKd3FefqFhp9jyhnp-LhGvQuxZ3vDTIdKDB3g#Head http://purl.org/np/RAwtpEE2QKd3FefqFhp9jyhnp-LhGvQuxZ3vDTIdKDB3g http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAwtpEE2QKd3FefqFhp9jyhnp-LhGvQuxZ3vDTIdKDB3g#assertion http://purl.org/np/RAwtpEE2QKd3FefqFhp9jyhnp-LhGvQuxZ3vDTIdKDB3g http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAwtpEE2QKd3FefqFhp9jyhnp-LhGvQuxZ3vDTIdKDB3g#provenance http://purl.org/np/RAwtpEE2QKd3FefqFhp9jyhnp-LhGvQuxZ3vDTIdKDB3g http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAwtpEE2QKd3FefqFhp9jyhnp-LhGvQuxZ3vDTIdKDB3g#pubinfo http://purl.org/np/RAwtpEE2QKd3FefqFhp9jyhnp-LhGvQuxZ3vDTIdKDB3g http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAwtpEE2QKd3FefqFhp9jyhnp-LhGvQuxZ3vDTIdKDB3g#assertion http://purl.obolibrary.org/obo/DOID_11102 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAwtpEE2QKd3FefqFhp9jyhnp-LhGvQuxZ3vDTIdKDB3g#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_11102 http://purl.org/np/RAwtpEE2QKd3FefqFhp9jyhnp-LhGvQuxZ3vDTIdKDB3g#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAwtpEE2QKd3FefqFhp9jyhnp-LhGvQuxZ3vDTIdKDB3g#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB00254 http://purl.org/np/RAwtpEE2QKd3FefqFhp9jyhnp-LhGvQuxZ3vDTIdKDB3g#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAwtpEE2QKd3FefqFhp9jyhnp-LhGvQuxZ3vDTIdKDB3g#association http://www.w3.org/2000/01/rdf-schema#label doxycycline hyclate tablets are tetracycline class drugs indicated for rickettsial infections 1 1 sexually transmitted infections 1 2 respiratory tract infections 1 3 specific bacterial infections 1 4 ophthalmic infections 1 5 anthrax including inhalational anthrax post exposure 1 6 alternative treatment for selected infections when penicillin is contraindicated 1 7 adjunctive therapy for acute intestinal amebiasis and severe acne 1 8 prophylaxis of malaria 1 9 to reduce the development of drug resistant bacteria and maintain the effectiveness of doxycycline hyclate tablets and other antibacterial drugs doxycycline hyclate tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria 1 1 doxycycline hyclate tablets are indicated for treatment of rocky mountain spotted fever typhus fever and the typhus group q fever rickettsial pox and tick fevers caused by rickettsiae doxycycline hyclate tablets are indicated for treatment of the following sexually transmitted infections uncomplicated urethral endocervical or rectal infections caused by chlamydia trachomatis nongonococcal urethritis caused by ureaplasma urealyticum lymphogranuloma venereum caused by chlamydia trachomatis granuloma inguinale caused by klebsiella granulomatis uncomplicated gonorrhea caused by neisseria gonorrhoeae chancroid caused by haemophilus ducreyi doxycycline hyclate tablets are indicated for treatment of the following respiratory tract infections respiratory tract infections caused by mycoplasma pneumoniae psittacosis ornithosis caused by chlamydophila psittaci because many strains of the following groups of microorganisms have been shown to be resistant to doxycycline culture and susceptibility testing are recommended doxycycline is indicated for treatment of infections caused by the following microorganisms when bacteriological testing indicates appropriate susceptibility to the drug respiratory tract infections caused by haemophilus influenzae respiratory tract infections caused by klebsiella species upper respiratory infections caused by streptococcus pneumoniae doxycycline hyclate tablets are indicated for treatment of the following specific bacterial infections relapsing fever due to borrelia recurrentis plague due to yersinia pestis tularemia due to francisella tularensis cholera caused by vibrio cholerae campylobacter fetus infections caused by campylobacter fetus brucellosis due to brucella bartonellosis due to bartonella bacilliformis because many strains of the following groups of microorganisms have been shown to be resistant to doxycycline culture and susceptibility testing are recommended doxycycline hyclate tablets are indicated for treatment of infections caused by the following gram negative microorganisms when bacteriological testing indicates appropriate susceptibility to the drug escherichia coli enterobacter aerogenes shigella acinetobacter urinary tract infections caused by klebsiella doxycycline hyclate tablets are indicated for treatment of the following ophthalmic infections trachoma caused by chlamydia trachomatis inclusion conjunctivitis caused by chlamydia trachomatis doxycycline hyclate tablets are indicated for the treatment of anthrax due to bacillus anthracis bacillus anthracis doxycycline hyclate tablets are indicted as an alternative treatment for the following selected infections when penicillin is contraindicated syphilis caused by treponema pallidum yaws caused by treponema pallidum pertenue listeriosis due to listeria monocytogenes vincent s infection caused by fusobacterium fusiforme actinomycosis caused by actinomyces israelii infections caused by clostridium in acute intestinal amebiasis doxycycline hyclate tablets may be a useful adjunct to amebicides in severe acne doxycycline hyclate tablets may be useful adjunctive therapy doxycycline hyclate tablets are indicated for the prophylaxis of malaria due to plasmodium falciparum see dosage and administration 2 4 patient counseling information 17 to reduce the development of drug resistant bacteria and maintain the effectiveness of doxycycline hyclate tablets and other antibacterial drugs doxycycline hyclate tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria when culture and susceptibility information are available they should be considered in selecting or modifying antibacterial therapy in the absence of such data local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy http://purl.org/np/RAwtpEE2QKd3FefqFhp9jyhnp-LhGvQuxZ3vDTIdKDB3g#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RAwtpEE2QKd3FefqFhp9jyhnp-LhGvQuxZ3vDTIdKDB3g#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAwtpEE2QKd3FefqFhp9jyhnp-LhGvQuxZ3vDTIdKDB3g#association https://w3id.org/biolink/vocab/relation https://schema.org/TreatmentIndication https://identifiers.org/drugbank:DB00254 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAwtpEE2QKd3FefqFhp9jyhnp-LhGvQuxZ3vDTIdKDB3g#provenance http://purl.org/np/RAwtpEE2QKd3FefqFhp9jyhnp-LhGvQuxZ3vDTIdKDB3g#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAwtpEE2QKd3FefqFhp9jyhnp-LhGvQuxZ3vDTIdKDB3g#pubinfo http://purl.org/np/RAwtpEE2QKd3FefqFhp9jyhnp-LhGvQuxZ3vDTIdKDB3g#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAwtpEE2QKd3FefqFhp9jyhnp-LhGvQuxZ3vDTIdKDB3g#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAwtpEE2QKd3FefqFhp9jyhnp-LhGvQuxZ3vDTIdKDB3g#sig http://purl.org/nanopub/x/hasSignature idFFoyWG34G4uVTWiMvPwfxUbnL9r1iprA2glofbpO3EcH/kep2ruUJrFn2K7xkMz5tUR7w7LYzq6T2jbcp04fd2pIVz4IhSqLWOkaVb5up21qY4O4fdgTKboj8TYZvryv+Pi5Jk7TiAGp21bR/V7HZIXNbD2NvYxeGjb05h79c= http://purl.org/np/RAwtpEE2QKd3FefqFhp9jyhnp-LhGvQuxZ3vDTIdKDB3g#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAwtpEE2QKd3FefqFhp9jyhnp-LhGvQuxZ3vDTIdKDB3g http://purl.org/np/RAwtpEE2QKd3FefqFhp9jyhnp-LhGvQuxZ3vDTIdKDB3g http://purl.org/dc/terms/created 2021-07-03T11:53:27.302+02:00 http://purl.org/np/RAwtpEE2QKd3FefqFhp9jyhnp-LhGvQuxZ3vDTIdKDB3g http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAwtpEE2QKd3FefqFhp9jyhnp-LhGvQuxZ3vDTIdKDB3g https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAwtpEE2QKd3FefqFhp9jyhnp-LhGvQuxZ3vDTIdKDB3g https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAwtpEE2QKd3FefqFhp9jyhnp-LhGvQuxZ3vDTIdKDB3g https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs